MedTrace Logo

A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging

NCT00556114 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2022-10-20

No results posted yet for this study

Summary

Growing evidence shows that altered blood flow plays a major role in many vision-threatening diseases including glaucoma, diabetic retinopathy, age-related macular degeneration, Central Retinal Vein Occlusion, and Branch Retinal Vein Occlusion. Optical coherence tomography, an established imaging technique use for eye exam in clinical ophthalmology, provides high-resolution cross sectional images of the retina and has increased our ability to understand many eye diseases.

Conditions

Interventions

DEVICE

Optical Coherence Tomography

Optical Coherence Tomography

Sponsors & Collaborators

  • Beckman Laser Institute University of California Irvine

    collaborator OTHER

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Baruch D Kuppermann,, M.D., Ph.D. · Ophthamology, University of California,Irvine

  • Zhongping Chen, Ph,D · Beckman Laser Institute University of California Irvine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00556114 on ClinicalTrials.gov